Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma

Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma

Show other versions (1)

Eddie J Gibson,1 Najida Begum,1 Ian Koblbauer,1 George Dranitsaris,2 Danny Liew,3 Phil McEwan,4 Yong Yuan,5 Ariadna Juarez-Garcia,6 David Tyas,6 Clive Pritchard1 1Wickenstones Ltd, Abingdon, UK; 2Augmentium Pharma Consulting Inc., Toronto, ON, Canada; 3School of Public Health and Preventive Medicine...

Full description

Bibliographic Details
Main Authors: Gibson EJ, Begum N, Koblbauer I, Dranitsaris G, Liew D, McEwan P, Yuan Y, Juarez-Garcia A, Tyas D, Pritchard C
Format: Article
Language:English
Published: Dove Medical Press 2020-05-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
immunotherapy
cost-effectiveness
melanoma
checkmate 067
Online Access:https://www.dovepress.com/economic-evaluation-of-single-versus-combination-immuno-oncology-thera-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/economic-evaluation-of-single-versus-combination-immuno-oncology-thera-peer-reviewed-article-CEOR

Similar Items